• / Free eNewsletters & Magazine
  • / My Account
Home>Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

3party Content

Wed, 22 Oct 2014

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.